IFRS 2 requires that shares and share options awarded to
employees are recognized as compensation expense based
on their fair value at grant date. In valuing share awards, the
employees entitlement to receive dividends during the vesting
period and post-vesting sale and hedge restrictions and
non-vesting conditions are taken into account. The share options
UBS issue to its employees have features that make
them incomparable to options on UBSs shares traded in active
markets. Accordingly, UBS cannot determine fair value
by reference to a quoted market price, but UBS rather estimates
it using an option valuation model. The model, a
Monte Carlo simulation, requires inputs such as interest
rates, expected dividends, volatility measures and specific
employee exercise behavior patterns based on statistical
data.
Some of the model inputs UBS uses are not market observable
and have to be estimated or derived from available
data. Use of different estimates would produce different option
values, which in turn would result in higher or lower
compensation expense recognized.
Several recognized models for the valuation of options
exist but none can be singled out as the best or most correct.
The model UBS applys has been selected because it is able to
handle some of the specific features included in the options
granted to UBSs employees. If UBS was to use a different
model, the option values produced would be different, even
if it used the same inputs.
Using both different inputs and a different valuation
model could have a significant impact on the fair value of
employee share options, which could be either higher or
lower than the values produced by the model UBS applys
and the inputs it has used.
On 1 January 2008, UBS adopted an amendment to
IFRS 2 Share-based Payment: Vesting Conditions and Cancellations
and restated the two comparative prior years. The
amended standard no longer considers non-compete conditions
to establish a service requirement in order to earn the
share-based awards. Accordingly, UBS changed its expense
recognition for compensation awards that contain non-compete
conditions from the stated vesting period to the period
over which the employee is required to provide active service
in order to earn the award. Post-vesting sale and hedge restrictions
and other non-vesting conditions are considered
when determining the fair value of an award at grant date.
The adoption of these IFRS 2 amendments had the effect
that the compensation expense for share and option awards
containing non-compete provisions was recognized retrospectively
in the year for which the award was granted. Additional
compensation expense of CHF 797 million was recognized
for 2007 and CHF 516 million for 2006.
In 2008,
management decided that most of the share-based awards
to be granted in March 2009 for the year 2008 will be forfeited
if the employee terminates employment with UBS
prior
to vesting and eliminated the non-compete conditions.
Compensation expense for these awards will be recognized
over the stated vesting period that commences on 1 March
2009. The adoption of the amendments to IFRS 2 and the
large reduction in variable compensation for 2008 resulting
in a small number of share grants related to 2008 significantly
reduced share-based compensation expense for 2008.
Further information on UBS equity compensation plans is
disclosed in Note 1a) 22) and Note 31 to the Financial Statements.